Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00280631 · ClinicalTrials.gov registry record · Phase 1
Study of TLK199 Tablets in Myelodysplastic Syndrome (MDS)
A Phase 1 study, sponsored by Telik.
- Completed
- Registry status
- Phase 1
- Development phase
- 49
- Enrollment target
NCT00280631 is a Phase 1 study that has completed, run by Telik. The registered enrollment target is 49 participants.
The verdict
NCT00280631, a Phase 1 study, has completed, sponsored by Telik.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 49 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the safety and efficacy of TLK199 Tablets in patients with Myelodysplastic Syndrome (MDS)
Interventions
- DRUG Ezatiostat Hydrochlorine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2006-02 |
| Est. Completion | 2008-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00280631
The ClinicalTrials.gov registry entry for NCT00280631 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Telik, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ezatiostat Hydrochlorine is the first listed.
NCT00280631 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00280631 about?
NCT00280631 is a clinical study titled "Study of TLK199 Tablets in Myelodysplastic Syndrome (MDS)". The purpose of this study is to determine the safety and efficacy of TLK199 Tablets in patients with Myelodysplastic Syndrome (MDS)
What is the current status of trial NCT00280631?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 49 participants. The study started on 2006-02. Estimated completion is 2008-06.
What interventions are being tested in trial NCT00280631?
The interventions under investigation include: Ezatiostat Hydrochlorine (DRUG).
Who is sponsoring clinical trial NCT00280631?
This trial is sponsored by Telik, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.